Stock Incentive Plan (Tables)
|
12 Months Ended |
Dec. 31, 2019 |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
|
Schedule of Stock-Based Compensation Expense Recognized |
The following table reflects the components of stock-based compensation expense recognized in the Consolidated Statements of Operations for the years ended December 31, 2019 and 2018:
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2018 |
|
|
2019 |
|
|
|
(Dollars
in
thousands)
|
|
Stock option compensation expense included in unallocated corporate expenses |
|
$ |
329 |
|
|
$ |
271 |
|
Restricted stock shares compensation expense included in unallocated corporate expenses |
|
|
— |
|
|
|
623 |
|
Stock option compensation expense included in broadcast operating expenses |
|
|
122 |
|
|
|
111 |
|
Restricted stock shares compensation expense included in broadcast operating expenses |
|
|
— |
|
|
|
383 |
|
Stock option compensation expense included in digital media operating expenses |
|
|
77 |
|
|
|
71 |
|
Restricted stock shares compensation expense included in digital media operating expenses |
|
|
— |
|
|
|
— |
|
Stock option compensation expense included in publishing operating expenses |
|
|
15 |
|
|
|
1 |
|
Restricted stock shares compensation expense included in publishing operating expenses |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
Total stock-based compensation expense, pre-tax
|
|
$ |
543 |
|
|
$ |
1,460 |
|
Tax expense from stock-based compensation expense |
|
|
(141 |
) |
|
|
(380 |
) |
|
|
|
|
|
|
|
|
|
Total stock-based compensation expense, net of tax |
|
$
|
402 |
|
|
$ |
1,080 |
|
|
|
|
|
|
|
|
|
|
|
Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of Stock Options and Restricted Stock Awards using Black-Scholes Option Valuation Model |
The weighted-average assumptions used to estimate the fair value of the stock options using the Black-Scholes valuation model were as follows for the years ended December 31, 2019 and 2018:
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2018 |
|
|
Year Ended December 31, 2019 |
|
|
|
|
41.84 |
% |
|
|
56.12 |
% |
|
|
|
7.89 |
% |
|
|
16.27 |
% |
|
|
|
7.4 |
|
|
|
6.7 |
|
|
|
|
2.93 |
% |
|
|
1.69 |
% |
|
Schedule of Stock Option Activity |
Activity with respect to the company’s option awards during the two years ended December 31, 2019 is as follows (Dollars in thousands, except weighted average exercise price and weighted average grant date fair value):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares |
|
|
Weighted Average Exercise Price |
|
|
Weighted Average Grant Date Fair Value |
|
|
Weighted Average Remaining Contractual Term |
|
|
Aggregate Intrinsic Value |
|
Outstanding at January 1, 2018 |
|
|
1,428,462 |
|
|
$ |
5.20 |
|
|
$ |
2.96 |
|
|
|
3.7 years |
|
|
$ |
653 |
|
|
|
|
650,000 |
|
|
|
3.30 |
|
|
|
1.86 |
|
|
|
|
|
|
|
— |
|
|
|
|
(17,615 |
) |
|
|
2.49 |
|
|
|
2.11 |
|
|
|
|
|
|
|
35 |
|
|
|
|
(79,875 |
) |
|
|
4.42 |
|
|
|
3.20 |
|
|
|
|
|
|
|
28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2018 |
|
|
1,980,972 |
|
|
$ |
4.63 |
|
|
$ |
2.61 |
|
|
|
4.1 years |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at December 31, 2018 |
|
|
1,055,716 |
|
|
|
5.51 |
|
|
|
3.38 |
|
|
|
2.2 years |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
878,531 |
|
|
$ |
4.65 |
|
|
$ |
2.63 |
|
|
|
4.0 years |
|
|
$ |
— |
|
|
|
|
|
|
|
Outstanding at January 1, 2019 |
|
|
1,980,972 |
|
|
$ |
4.63 |
|
|
$ |
2.61 |
|
|
|
4.1 years |
|
|
$ |
0 |
|
|
|
|
88,750 |
|
|
|
1.63 |
|
|
|
0.44 |
|
|
|
0 |
|
|
|
0 |
|
|
|
|
(200 |
) |
|
|
2.38 |
|
|
|
2.05 |
|
|
|
0 |
|
|
|
0 |
|
|
|
|
(208,800 |
) |
|
|
5.77 |
|
|
|
4.06 |
|
|
|
0 |
|
|
|
2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2019 |
|
|
1,860,722 |
|
|
$ |
4.39 |
|
|
$ |
2.37 |
|
|
|
3.6 years |
|
|
$ |
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at December 31, 2019 |
|
|
1,248,844 |
|
|
|
4.93 |
|
|
|
2.78 |
|
|
|
2.3 years |
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
580,978 |
|
|
$ |
4.40 |
|
|
$ |
2.38 |
|
|
|
3.5 years |
|
|
$ |
0 |
|
|
Schedule of Information Regarding Restricted Stock Activity |
Activity with respect to the company’s restricted stock awards during the year ended December 31, 2019 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares |
|
|
Weighted Average Grant Date Fair Value |
|
|
Weighted Average Remaining Contractual Term |
|
|
Aggregate Intrinsic Value |
|
Non-Vested at January 1, 2019 |
|
|
— |
|
|
$ |
— |
|
|
|
— years |
|
|
$ |
— |
|
|
|
|
497,051 |
|
|
|
2.02 |
|
|
|
— |
|
|
|
1,006 |
|
|
|
|
(389,061 |
) |
|
|
2.07 |
|
|
|
— |
|
|
|
919 |
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2019 |
|
|
107,990 |
|
|
$ |
1.85 |
|
|
|
1.67 years |
|
|
$ |
156 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Options Outstanding Additional Information |
Additional information regarding options outstanding as of December 31, 2019, is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contractual Life |
|
Weighted |
|
|
|
|
|
Weighted |
|
Range of |
|
|
|
|
Remaining |
|
Average |
|
|
Exercisable |
|
|
Average |
|
|
|
Options |
|
|
(Years) |
|
Exercise Price |
|
|
Options |
|
|
Exercise Price |
|
|
|
|
357,005 |
|
|
3.0 |
|
$ |
2.43 |
|
|
|
268,255 |
|
|
$ |
2.70 |
|
|
|
|
565,000 |
|
|
5.7 |
|
|
3.25 |
|
|
|
176,500 |
|
|
|
3.25 |
|
|
|
|
67,750 |
|
|
5.4 |
|
|
3.78 |
|
|
|
20,125 |
|
|
|
3.81 |
|
|
|
|
411,792 |
|
|
3.7 |
|
|
4.85 |
|
|
|
324,789 |
|
|
|
4.85 |
|
|
|
|
10,750 |
|
|
1.4 |
|
|
5.68 |
|
|
|
10,750 |
|
|
|
5.68 |
|
|
|
|
448,425 |
|
|
1.1 |
|
|
7.00 |
|
|
|
448,425 |
|
|
|
7.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,860,722 |
|
|
3.6 |
|
$ |
4.39 |
|
|
|
1,248,844 |
|
|
$ |
4.93 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|